Xeris Pharmaceuticals | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Celltrion KRW 273.99B 95.74B 2024-12
Cspc Pharmaceutical CNY 944.38M 798.51M 2024-09
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Kangmei Pharma -5720000 15.38M 2024-09
Knight Therapeutics CAD -7144000 19.01M 2024-03
Laboratorios Farma 121.55M 84.42M 2024-12
Medical Developments International AUD -6390000 0 2023-12
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Organigram Holdings CAD -22957000 4.15M 2024-12
Pacira USD 49.58M 8.89M 2024-09
Perrigo USD 151.3M 11.9M 2024-12
Pharma Mar EUR 9.54M 5.66M 2024-12
Qiagen NV USD 169.1M 52.64M 2024-12
Sartorius EUR 30.8M 21.6M 2024-09
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
Tilray USD -83239000 49.47M 2024-11
Zz Pientze Pharmaceu 1.13B 234.17M 2024-09



Xeris Pharmaceuticals Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.